Effects of candesartan on angiotensin II-induced renal vasoconstriction in rats and mice

Journal of the American Society of Nephrology

Volumn 10, Issue 1 SUPPL. 11, 1999, Pages

  Ruan, Xiaoping ^a   Purdy, Kit E ^a   Oliverio, Michael I ^b   Coffman, Thomas M ^b   Arendshorst, William J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; INDOMETACIN; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SPONTANEOUSLY HYPERTENSIVE RAT; VASOCONSTRICTION; VASODILATATION;

EID: 0032905570     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Chatziantoniou C, Arendshorst WJ: Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension. Am J Physiol 259: F372-F382, 1993
2. 1 subtypes in renal afferent arterioles during chronic changes in sodium diet. J Clin Invest 99: 1072-1081, 1997
3. Tofovic SP, Pong AS, Jackson EK: Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats. Hypertension (Dallas) 18: 774-782, 1991
4. Xie MH, Liu FY, Wong PC, Timmermans PB, Cogan MG: Proximal nephron and renal effects of Dup 753, a nonpeptide angiotensin II receptor antagonist. Kidney Int 38: 473-479, 1990
5. Soltis EE, Jewell AL, Dwoskin LP, Cassis LA: Acute and chronic effects of losartan (Dup 753) on blood pressure and vascular reactivity in normotensive rats. Clin Exp Hypertens 15: 171-184, 1993
6. 1 receptors. Am J Physiol 270: F749-F755, 1996
7. Shibouta Y, Inada Y, Ojima M, Wada T, Noda M, Sanada T, Kubo K, Kohara Y, Naka T, Nishikawa K: Pharmacological profile of a highly potent and long-term-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole- 7-carboxylic acid (CV-11974), and its prodrug, (±)-1-(cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-[[2′-(1H-tetrazol- 5-yl)biphenyl-4-yl]methyl]-lH-benzimidazole-7-carboxylate (TCV-116). J Pharmacol Exp Ther 266: 114-120, 1993
8. Inada Y, Wada T, Shibouta Y, Ojima M, Sanada T, Ohtsuki K, Itoh K, Kubo K, Kohara Y, Naka T, Nishikawa K: Antihypertensive effects of a highly potent and long-term-acting angiotensin n subtype-1 receptor antagonist, (±)-1-(cyclohexyloxycarbonyloxy)-ethyl-2-ethoxy-1-[[2′-(1H- tetrazol-5-yl)biphenyl4-yl]-methyl]-1H-benzimidazole-7-carboxylate (TCV-116).J Pharmacol Exp Ther 268: 1540-1547, 1994
9. Noda M, Shibouta Y, Inada Y, Ojima YM, Wada YT, Sanada T, Kubo K, Kohara Y, Naka T, Nishikawa K: Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new non-peptide AII antagonist. Biochem Pharmacol 46: 311-318, 1993
10. 1 receptor. Eur J Pharmacol 220: 267-270, 1992
11. 1 receptor antagonist CV-11974 in conscious renal hypertensive rats. Hypertension (Dallas) 26: 989-997, 1995
12. Chansel DC, Liorens-Cortes S, Vandemeersch P, Pham P, Ardaillou R: Regulation of angiotensin II receptor subtypes by dexamethasone in rat mesangial cells. Hypertension (Dallas) 27: 867-874, 1996
13. Ideishi M, Minra S, Sakai T, Maeda H, Kinossita A, Sasaguri M, Jimi S. Arakawa K: Comparative effects of an angiotensin-converting enzyme inhibitor and an angiotensin II antagonist in Dahl rats. Blood Press Suppl 5: 99-104, 1994
14. Takishita S, Muratani H, Sesoko S, Tozawa M, Fukiyama K, Inada Y: Short-term effects of angiotensin II blockade on renal blood flow and sympathetic activity in awake rats. Hypertension (Dallas) 24: 445-450, 1994
15. Murphy TJ, Alexander WR, Griendling KK, Runge MS, Bernstein KE: Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature (Lond) 351: 233-236, 1991
16. Sasaki K, Yamano YY, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T: Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature (Lond) 351: 230-233, 1991
17. Sasamura H, Hein L, Krieger JE, Pratt RE, Kobilka BK, Dzau VJ: Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun 185: 253-259, 1992
18. Chansel DC, Liorens-Cortes S, Vandemeersch P, Pham P, Ardaillou R: Regulation of angiotensin II receptor subtypes by dexamethasone in rat mesangial cells. Hypertension (Dallas) 27: 867-874, 1996
19. 1A receptor deficient mice. Hypertension (Dallas) 31: 1171-1177, 1998
20. Wolf K, Della-Bruna R, Brucckschlegel G, Schunkert H, Rigger GAJ, Kurtz A: Angiotensin II receptor gene expression in hypertrophied left ventricles of rat hearts. J Hypertens 14: 349-354, 1996
21. Kakar SS, Sellers JC, Devor DC, Musgrove LC, Neill JD: Angiotensin II type-1 receptor cDNAs: Differential tissue expression and hormonal regulation. Biochem Biophys Res Commun 183: 1090-1096, 1992
22. Kimura K, Tojo A, Hirata Y, Hayakawa H, Goto A, Omata M: Effects of a calcium antagonist and an angiotensin II receptor antagonist on rat renal arterioles. Blood Press Suppl 5: 71-74, 1994
23. Chatziantoniou C, Daniels FH, Arendshorst WJ: Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol 265: F853-F862, 1993
24. Ito M, Oliverio M, Mannon P, Best C, Smithies NO, Coffman TM: Regulation of blood pressure by the type 1A receptor for angiotensin II. Proc Natl Acad Sci USA 92: 3521-3525, 1995
25. Chatziantoniou C, Arendshorst WJ: Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats. Am J Physiol 263: F573-F580, 1992
26. 1 receptors are essentially identical. Biochem Biophys Res Commun 188: 298-303, 1992
27. 1b receptor mRNA. Biochem Biophys Res Commun 188: 298-303, 1992
28. 1B receptors in blood pressure regulation. Am J Physiol 272: F515-F520, 1997
29. Sugaya T, Nishimatsu S, Tanimoto K, Takimoto E, Yamagishi T, Imamura K, Goto S, Imaizumi K, Hisada Y, Otsuka A: Angiotensin II type 1A receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 270: 18719-18722, 1995
30. Chen X, Li W, Yoshida H, Tsuchida S, Nishimura H, Takemoto F, Okubo S, Fogo A, Matsusaka T, Ichikawa I: Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol 272: F299-F304, 1997
31. Tsuchida S, Matsusaka T, Chen X, Okubo S, Niimura F, Nishimura H, Fogo A, Utsunomiya H, Inagami T, Ichikawa I: Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes. J Clin Invest 101: 755-760, 1998
32. 1b angiotensin receptors expressed in adrenocortical Y-1 cells. Am J Physiol 270: E831-E839, 1996
33. Sandberg K, Ji H, Clark AJL, Shapira H, Catt KJ: Cloning and expression of a novel angiotensin II receptor. J Biol Chem 267: 9455-9458, 1992
34. 1B gene as a candidate for blood pressure. J Hypertens 12: 1001-1006, 1994
35. Hara M, Kiyama R, Nakajima S, Kawabata T, Kawakami M, Ohtani K, Itazaki K, Fujishita T, Fujimoto M: Kinetic studies on the interaction of nonlabeled antagonists with the angiotensin II receptor. Eur J Pharmacol 289: 267-273, 1995